Metraipolis › archive › dc_2f32ba920669

Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics — Europe PMC PMID:41007659

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007659
DOI
10.3390/biomedicines13092096
License (as archived)
solo-consultazione
Archived
2026-11-10T07:18:41.417Z
SHA-256 of the archived text
3fe971e64d80111c502668a4d65b9deef9e240f828b4ca236e10fc08adcea34c
Stable URL of this page
https://metraipolis.com/documento/dc_2f32ba920669

How to cite

Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics — Europe PMC PMID:41007659 — Europe PMC (en), https://europepmc.org/article/MED/41007659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f32ba920669 (Metraipolis archive dc_2f32ba920669, sha256 3fe971e64d80111c502668a4d65b9deef9e240f828b4ca236e10fc08adcea34c)
BibTeX
@misc{dc2f32ba920669,
  title = {Biomarker-Associated Remission After Switching to Dupilumab in Severe Asthma Following Failure of Prior Biologics — Europe PMC PMID:41007659},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007659},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f32ba920669; sha256 3fe971e64d80111c502668a4d65b9deef9e240f828b4ca236e10fc08adcea34c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007659. Agents can read the archived copy with the MCP tool read_document.